Work

Phase II trial of branched peginterferon-α 2a (40 kDa) for patients with advanced renal cell carcinoma

Year: 2002

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdf288

Authors: R.J. Motzer, A. Rakhit, J. Thompson, H. Gurney, P. Selby, R. Figlin, S. Negrier, S. Ernst, M. Siebels, M. Ginsberg, K. Rittweger, L. Hooftman

Institutions: Memorial Sloan Kettering Cancer Center, University of Washington Medical Center, St James's University Hospital, Westmead Hospital, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Centre Léon Bérard, Ludwig-Maximilians-Universität München

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2117686153

FWCI: 4.921

Cites: 15

Cited by: 53

Related to: 10